Dermatol. praxi. 2012;6(1):26-28

Folliculitis decalvans capillitii

MUDr.Jana Zímová1, doc.MUDr.Lumír Pock, CSc.2
1 Středomoravská nemocniční a. s., odštěpný závod Nemocnice Přerov, Kožní ambulance
2 Dermatohistopatologická laboratoř, Praha 8

Folliculitis decalvans (FD) is a rare variant of primary neutrophilic cicatricial alopecia. The etiopathogenesis is not fully understood.

Young and middle – aged adults of both sexes are typically affected, but more men. Staphylococcus aureus is frequently isolated from

follicular pustules. The disease is permanently progressive but after treatment interruption relapses are common. We describe a case of

51-year-old woman successfully treated with combination of cefuroxim axetil, clindamycin and zinc sulfate.

Keywords: folliculitis decalvans capillitii, Staphylococcus aureus, primary cicatricial alopecia, diagnosis, treatment

Published: March 20, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zímová J, Pock L. Folliculitis decalvans capillitii. Dermatol. praxi. 2012;6(1):26-28.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Price V, Mirmirani P. Cicatrical Alopecia: An Approach to Diagnosis and Management. Springer Science Business Media, 2011: 1-5, 61-68. Go to original source...
    2. Štork J, et al. Dermatovenerologie. 1. vydání. Praha: Galén, 2008: 284.
    3. Blume-Peytavi U, Tosti A, Whiting DA, Trueb RM, (Eds.). Hair Growth and Disorders. Springer-Verlag Berlin Heidelberg, 2008: 187-189, 208-211. Go to original source...
    4. Olsen EA, Bergfeld WF, Cotsarelis G, et al. Summary of North American Hair Research Society (NAHRS) - sponsored Workshop on Cicatrical Alopecia, Duke University Medical Center, February 10 and 11. J Am Acad Dermatol, 2003; 48: 103-110. Go to original source... Go to PubMed...
    5. Quinquaud E. Folliculite epilante et destructive des regions velues. Bull Mem Soc Hop Paris 1888; 5: 395-398.
    6. Otberg N, Kang H, Alzolibani AA, Shapiro J. Folliculitis decalvans. Dermatologic Therapy 2008; 21: 238-244. Go to original source... Go to PubMed...
    7. Douwes KE, Landthaler M, Szeimies RM. Simultaneous occurence of folliculitis decalvans capillitii in identical twins. Br J Dermatol 2000; 143: 195-197. Go to original source... Go to PubMed...
    8. Arenberger P, a kol. Klinická trichologie. Praha: MAXDORF, 2002: 87-88.
    9. Braun-Falco O, Plewig G, Wolff HH. Dermatológia a venerológia. Martin: Osveta, 2001: 172-173. Go to original source...
    10. Tosti A, Piraccini BM. Diagnosis and Treatment of Hair Disorders. An Evidence Based Atlas. UK: Taylor & Francis group, 2006: 114-115. Go to original source...
    11. Barnhill RL, Crowson AN, Margo CM, Piepkorn MW. Dermatopathology Third Edition. The McGraw-Hill Companies Inc., 2010: 230.
    12. Sperling LC. An Atlas of Hair Pathology With Clinical Correlations. USA NY, UK London: The Parthenon Publishing Group, 2003: 232. Go to original source...
    13. Hynie S. Speciální farmakoterapie Díl VII/B Protiinfekční léčiva. Praha: Karolinum, 2003: 61-75, 92-112, 118, 133-151.
    14. Gemmke A, Wollina U. Folliculitis decalvans of scalp: Response to tripple therapy with isotretinoin, clindamycin, and prednisolone. Acta Dermatoven APA, 2006; 15(1): 184-186.
    15. Chiarini C, Torchia D, Bianchi B, Volpi W, Caproni M, Fabbri P. Immunopathogenesis of Folliculitis decalvans Clues in Early Lesions. Am J Clin Pathol, 2008; 130: 526-534. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.